Janssen

YONDELIS

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Janssen

Yondelis HCPCS:

J9352

HCPCS Code Descriptor:

Injection, trabectedin, 0.1 mg

Category:

J Code

Yondelis NDCs:

59676-0610-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Yondelis CPT Codes:

Potential CPT administration codes for Yondelis can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Yondelis:

YONDELIS is an Oncology drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9352 is aligned to the drug YONDELIS.

Yondelis is a type of chemotherapy drug. It is often used to treat a type of cancer called soft tissue sarcoma, which has spread to other parts of the body. Yondelis may be prescribed to patients with metastatic liposarcoma or leiomyosarcoma who have not responded to other forms of treatment. Yondelis is thought to work by interfering with the growth and spread of cancer cells in the body.

ACCESS PRICING AND MORE BY REGISTERING

J9352 Added Date:

January 1, 2017

J9352 Effective Date:

January 1, 2017

J9352 Termination Date:

HCPCS Active

Yondelis billing and coding information can be found through Janssen at the link below:
Yondelis patient assistance information can be found through the Johnson and Johnson Patient Assistance Foundation at the URL: http://www.jjpaf.org/
YONDELIS prescribing information can be found at the link below:
Information regarding YONDELIS’s side effects can be found at MedlinePlus